Mahmoud Jaber

Experience

• 

  King Saud University

  Jun 2015 - Jun 2016

  PharmD Internship Program

  Clinical, non-clinical, research and pharmaceuticals company rotations at different institutions and companies.

• 

  Extreme Nutrition

  Oct 2016 - Dec 2016

  Salesman

  Products specialist and nutrition advisor.

• 

  Dr. Sulaiman AL Habib Medical Group

  Jan 2017 - Mar 2017

  Pharmacist

  Inpatient Pharmacy - IV room and chemotherapy admixtures

• 

  Sandoz

  Mar 2017 - Feb 2019

  • Governmental sector Key Account Specialist responsible for both company strategic medicines including "BIO-similars" promotionally, and total portfolio commercially in main institutions as KFSHRC-R, Riyadh Medical Supply hospitals, Qurayyat Medical Supply hospitals, Habib.• MOH, NUPCO and GHC Market Access. Omnitrope® (somatropin) | Binocrit® (epoetin alfa) | Zarzio® (filgrastim) | Aclasta® (zoledronic acid) | Ramipril |

  • Key Account Specialist

    Jan 2018 - Feb 2019

  • Medical Sales Representative

    Mar 2017 - Jan 2018
• 

  NewBridge Pharmaceuticals

  Mar 2019 - Feb 2020

  Immunology & Rare Diseases Product Specialist

  • Responsible promotionally and commercially for both Immunology and Rare diseases BUs products, covering main assigned accounts under MOH, Institutions and Private Accounts in Riyadh, Qassim, Hail and Eastern Province.• Responsible for the total company portfolio for MOH directory and as MOH and NUPCO Market Access.• Launched products: CIMZIA® (certolizumab pegol), for UCB. OCALIVA® (obeticholic acid), for Intercept Pharmaceuticals.

• 

  Sanofi Genzyme

  Jan 2020 - now

  Key Account Manager

  • Launched Dupixent for both respiratory indications, Severe Asthma and CRSwNP.• Assuring the brand strategy and objectives applied and aligned across all internal and external stakeholders and accelerate the inclusion in all key accounts formulary to be accessible and available for the patients. • Overachieving the assigned targets and KPIs.Dupixent® (Dupilumab)